RS5444, a novel PPARγ agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells-Reference-Cited by-同舟云学术

RS5444, a novel PPARγ agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells

Published:2006-06 Issue:1-2 Volume:251 Page:17-32
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Chen Lu,Bush Craig R.,Necela Brian M.,Su Weidong,Yanagisawa Masahiro,Anastasiadis Panos Z.,Fields Alan P.,Thompson E. Aubrey

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference57 articles.

1. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma) ligand, selectively induces the early growth response-1 gene independently of PPARgamma. A novel mechanism for its anti-tumorigenic activity;Baek;J. Biol. Chem.,2003

2. Controlling the false discovery rate: a practical and powerful approach to multiple testing;Benjamini;J. R. Stat. Soc. Ser. B,1995

3. Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells;Brockman;Gastroenterology,1998

4. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer;Chang;Cancer Res.,2000

5. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis;Conery;Nat. Cell Biol.,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development;European Journal of Pharmacology;2024-02

2. Peroxisome proliferator‐activated receptors as therapeutic target for cancer;Journal of Cellular and Molecular Medicine;2023-09-12

3. PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer;Cells;2022-10-13

4. Novel Target Sites for Drug Screening: A Special Reference to Cancer, Rheumatoid Arthritis and Parkinson’s Disease;Current Signal Transduction Therapy;2019-10-10

5. Transcriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma Cells;Molecular Pharmacology;2016-08-26